期刊文献+

环氧合酶-2在子宫肌瘤组织中的表达及其意义 被引量:4

The expression and pathogenetic roles of cyclooxygenase-2 in uterine fibroids
下载PDF
导出
摘要 目的观察环氧合酶-2(cyclooxygenase,COX-2)在子宫肌瘤与子宫平滑肌组织中的表达,探讨COX-2与子宫肌瘤发病机制的相关性。方法选择2010年1月至2010年8月在上海市杨浦区中心医院行腹腔镜下子宫肌瘤切除术的30例患者的子宫肌瘤组织为实验组,并取其邻近的正常平滑肌组织为对照组,采用免疫组化方法检测COX-2的表达;并采用蛋白印迹法及实时荧光定量逆转录聚合酶链反应分别在蛋白水平和基因转录水平检测标本中COX-2的表达。结果免疫组化检测实验组和对照组均有COX-2蛋白表达,平滑肌细胞阳性指数(MPI)为11.90,子宫肌瘤细胞阳性指数(FPI)为46.50,两者比较,差异有统计学意义(P<0.05)。蛋白印迹法结果显示,COX-2在实验组(0.872±0.035)中的表达明显高于对照组(0.202±0.056),两者比较,差异有统计学意义(P<0.05)。COX-2mRNA在实验组(0.122±0.062)中的表达也高于对照组(0.025±0.009),两者比较,差异有统计学意义(P<0.05)。结论 COX-2在子宫肌瘤的表达明显高于子宫平滑肌,COX-2可能在子宫肌瘤的发病机制中起重要作用。 Objective To detect the expression of cyclooxygenase - 2 (COX- 2) in uterine fibroids and normal uterine smooth muscles thus to investigate its roles in the pathogenesis of uterine fibroids. Methods To detect the expression of cyclooxygenase - 2 in uterine fibroids and normal uterine smooth muscle thus to investigate its roles in the pathogenesis of uterine fibroids. Results the COX - 2 positive index in smooth muscle cells (11.90) was much lower than that in uterine fibroids cells (46.50, P〈0.05). At protein level, the COX- 2 expression in uterine fibroids was significantly higher than in smooth muscle (0. 872 4±0. 035 vs 0. 202 ±0. 056). Similarly, at mR- NA level, COX- 2 expression in uterine fibriods (0. 122 ± 0. 062) was higher than in normal smooth muscle tissue (0. 025 4± 0. 009) (P〈0. 05). Conclusion COX- 2 expression in uterine fibroids was significantly higher than uterine smooth muscles, suggesting an imoortant role nf COX - 2 in the pathogenesis of uterine fibroids.
出处 《中国妇产科临床杂志》 2012年第6期446-449,共4页 Chinese Journal of Clinical Obstetrics and Gynecology
关键词 子宫肌瘤 环氧合酶-2 前列腺素 免疫组织化学 uterine fibroid cyclooxygenase - 2 prostaglandin immunohisbochemistry
  • 相关文献

参考文献11

  • 1Menter DG, Dubois RN. Prostaglandins in cancer cell adhe- sion, migration, and invasion. Int J Cell Biol, 2012, 2012: 723419.
  • 2Soumaom LT, Uetake H, Takagi Y. Coexpression of VEGF- C and Cox- 2 in human colorectal cancer and its association with lymph node metasia Dis Colon Rectum, 2006, 49:392 - 398.
  • 3Abrahao AC, Castilho RM, Squarize CH, et al. A role for COX2 - derived PGE2 and PGE2 - receptor subtypes in head and neck squamous carcinoma cell proliferation. Oral Oncol, 2010, 46: 880-887.
  • 4Parker WH. Etiology, symptomatology, and diagnosis of u terinemyomas. Fertil Steril, 2007, 87: 725-736.
  • 5Dias Am Garcia C, Majewski M, et al. Gastric juice prosta- glandins and peptide growth factors as potential markers of chronic atrophic gastritis, intestinal metaplasia and gastric cancer: their potential clinical implications based on this pilot study. Dig DisSci, 2011, 56: 3220-3225.
  • 6Kim HS, Moon HG, Han W, et al. COX2 overexpression is a prognostic marker for stage Ill breast cancer. Breast Cancer Res Treat, 2012, 132:51 - 59.
  • 7Choi J, Chang H. The expression of MAGE and SSX, and correlation of COX2, VEGF, and survivin in colorectal canc- er. AnticancerRes, 2012, 32: 559-564.
  • 8Zhao QT, Yue SQ, Cui Z, et al. Potential involvement of the cyclooxygenase - 2 pathway in hepatocellular carcinoma - associated angiogensis. Life Sci, 2007, 80.. 484- 492.
  • 9杨晓文,崔明,王世清,莫平.乳腺癌组织COX-2和Bcl-2蛋白表达及其临床意义[J].中华肿瘤防治杂志,2009,16(4):295-298. 被引量:9
  • 10Karahan N, Giiney M, Baspinar S, et al. Expression of ge- latinase (MMP - 2 and MMP - 9 ) and cyclooxygense - 2 (COX - 2) in endornetrial carcinoma. Eur J Gynaecol Oncol, 2007, 28: 184-188.

二级参考文献16

  • 1陈丽昆,何友兼,黄河,廖海,韩冰.选择性COX-2抑制剂对非小细胞肺癌细胞株毒性及分子机制的研究[J].中华肿瘤防治杂志,2007,14(12):901-904. 被引量:7
  • 2Parkin D M, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J].CA Cancer J Clin, 2005, 55(2) :74-108.
  • 3Wu Y L, Sun B,Zhang X J, et al. Growth inhibition and apoptosis induction of Sulindac on Human gastric cancer cells[J].World J Gastroenterol, 2001, 7(6): 796 -800.
  • 4Petros A M, Olejniczak E T, Fesik S W. Structural biology of the Bcl-2 family of proteins[J].Biochim Biophys Acta, 2004, 1644(2-3) :83-94.
  • 5Leo C, Faber S, Hentschel B, et al. The status of cyclooxygenase-2 expression in ductal carcinoma situ lesions and invasive breast cancer correlates to eyelooxygenase-2 expression in normal breast tissue[J]. Ann Diagn Pathol, 2006,10(6) :327- 332.
  • 6Nystrom M L, Mcculloch D, Weinreb P H, et al. Cyclooxygenase- 2 inhibition suppresses alphavbeta 6 integrindependent oral squamous carcinoma invasion[J]. Cancer Res,2006, 66(22):10833- 10842.
  • 7Harris R E, Alshafie G A, Abou-Issa H, et al. Chemoprevention ofbreast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor[J]. Cancer Res,2000, 60(8): 2101-2103.
  • 8Tsujimoto Y, Yunis J, Lonorato-showe, et al. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the chromosome translocation [J]. Science, 1984, 224(4656):1403-1406.
  • 9Hellemans P,Van Dam P A,Weyler J, et al. Prognostic value of Bcl-2 expression in invasive breast cancer[J].Br J Cancer, 1995, 73(3): 354-360.
  • 10Fosslien E. Molecular pathology of cyclooxygenase-2 in neoplasia[J]. Ann Clin Lab Sci,2000, 30(1) : 3-21.

共引文献8

同被引文献31

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部